Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
about
Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failureTargeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathyCardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure.Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization.The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.Autoantibodies and cardiovascular dysfunction: cause or consequence?Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice.Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications.PD-1/PD-L pathway and autoimmunity.Therapeutic apheresis--state of the art in the year 2005.Risk of idiopathic dilated cardiomyopathy in 29 000 patients with celiac disease.Immune modulation therapy in heart failure.How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.Immunoadsorption as treatment option in dilated cardiomyopathy.Conventional apheresis therapies: a review.Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart functionApheresis in the treatment of idiopathic dilated cardiomyopathy.Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management.Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.The selective therapeutic apheresis procedures.Immunoadsorption therapy in dilated cardiomyopathy.Viral myocarditis--diagnosis, treatment options, and current controversies.Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution.The tumor necrosis factor superfamily in heart failure.The therapeutic potential of immune therapy in idiopathic dilated cardiomyopathy.Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-κB pathway.Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy.Sera from patients with idiopathic dilated cardiomyopathy decrease ICa in cardiomyocytes isolated from rabbits.Effects of autoantibodies removed by immunoadsorption from patients with dilated cardiomyopathy on neonatal rat cardiomyocytes.Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.Outcomes of plasma exchange for severe dilated cardiomyopathy in children.Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
P2860
Q24652847-ED31C8CE-2D12-45D8-A1CE-8DAD6B4645C3Q27000434-467046CF-2080-41C2-BF3F-9F1A669E22C8Q33641429-A8035C21-5EC9-4731-B217-E2FBD86E14D2Q33813731-625D3E4F-F264-4742-B422-3B415FDB6AA3Q34122035-E247A8E3-B7D2-49E6-B635-FFB90673DA98Q34315311-1C45CA9C-7E68-4C08-9126-2E4C41B44DB3Q34418753-2FD2E605-3077-4484-901D-26886B28F308Q34473885-CA2A51F5-BC5E-4E0D-90DA-71717A50B9D8Q34543002-A0C91127-8D2C-4428-9BD7-D55197506592Q34632155-5D70F8D9-6007-46AA-BFE4-45BC040CBC3CQ36198484-40AC1F45-8ED4-45F1-8E7B-1BB78958A315Q36287532-7B2B0574-DE76-4C9C-BC49-140C160D429AQ36341821-0B4A343E-CFFA-400A-832F-22F6FE1E0E1EQ36366171-C8769EDA-D646-494F-839B-29E4099E3D14Q36440971-6E7B3E08-CAA1-436F-B5EE-BCDC716BA3EBQ37004826-91BB84CC-F7A6-46B2-AB61-93FC44DEBF46Q37051232-8348D402-F6B1-4F8D-B757-39E9F8C13594Q37090971-6AFAC10E-61FB-4D85-A7E3-2C2D17EB5538Q37264384-B79DFC4D-6BA0-4D6E-B09C-95D6C9FAA0B3Q37924701-FAC4BFBB-7450-4234-B1E6-F191968E62D8Q37973384-AB2EF0C8-4B53-4A48-AA69-315052F53CB8Q38027456-4652F509-F112-485A-B2EE-882C7EC89E51Q38045203-1CDF867C-0A08-4AB2-9249-FAB7597E5849Q38056870-A6DE0920-217F-4BC3-A74E-7A43945F270CQ38066111-9DB1E1AC-9489-4891-9B6A-F26A0786E55AQ38082734-D2BE0FFC-1643-4757-AFC0-C45912584B71Q38286190-A82088C9-E1EF-40BC-9390-3E6153CBBA13Q38551013-CC5483AE-1466-4C9E-BC7E-5A6F83944F54Q39604148-71DFF07F-14C8-4884-A5A1-AB036747E724Q40361542-DA8451F3-DB00-4073-9827-33A6662904E8Q40393628-E6B7B832-1532-4CE5-B28B-3D0AD219FA83Q42652420-58B22E59-8AEE-475F-97B1-D859BBC343B9Q43626109-42A9E81F-DFBC-42DF-AA59-B8AFA68458A8Q44980684-CEDF8A9B-AB11-409F-A0B0-770DD78912A3Q46937186-D9E5B63D-E86E-4D76-AA51-B1B12E34B714Q48607244-9EC9EC75-8F18-49B8-9086-403BD0736B22Q51354832-69702292-F19A-4D7A-87A6-91F706DB6415Q52887237-D7B28C39-AEA2-45D7-AC82-E3CA7A64DC2F
P2860
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
@ast
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
@en
type
label
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
@ast
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
@en
prefLabel
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
@ast
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
@en
P2093
P1476
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
@en
P2093
Alexander Staudt
Gert Baumann
Karl Stangl
Martin Landsberger
Stephan B Felix
Thomas Spielhagen
Verena Stangl
Yvonne Grosse
P304
P356
10.1016/S0735-1097(01)01794-6
P407
P577
2002-02-01T00:00:00Z